Citations

Showing 10 of 107964 citations.

F3‐02‐02: MCI Incidence, progression to dementia, and reversion to normal in a population‐based cohort: The mayo clinic study of aging
Roberts, Rosebud O.

Mayo Clinic

Alzheimer's & Dementia | January 12, 2012 | Volume: 7 | Issue: 4S_Part_14 | Pages: No page available

10.1016/j.jalz.2011.05.2381 Get It

P1‐232: Maternal Transmission of Alzheimer's Disease
Heggeli, Kristin, Thomas, Colleen S. , Crook, Julia E. , Graff‐Radford, Neill, Graff‐Radford, Neill

Mayo Clinic

Alzheimer's & Dementia | January 12, 2012 | Volume: 7 | Issue: 4S_Part_5 | Pages: No page available

10.1016/j.jalz.2011.05.512 Get It

P2‐191: Investigating the association between fasting serum glucose levels and cerebral metabolic rate for glucose in brain regions affected by Alzheimer's disease
Burns, Christine , Kaszniak, Alfred W., Lee, Wendy , Alexander, Gene E. , Bandy, Daniel, Fleisher, Adam , Caselli, Richard J. , Reiman, Eric M. , Chen, Kewei

Mayo Clinic

Alzheimer's & Dementia | January 12, 2012 | Volume: 7 | Issue: 4S_Part_24 | Pages: No page available

10.1016/j.jalz.2011.09.024 Get It

P4‐472: Vasogenic edema in the setting of ß‐amyloid lowering therapy, adverse event: what is it and how is it detected?
Barakos, Jerome , Carlson, Christopher, Estergard, Wahiba, Oh, Joonmi, Suhy, Joyce, Siemers, Eric , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | January 12, 2012 | Volume: 7 | Issue: 4S_Part_25 | Pages: No page available

10.1016/j.jalz.2011.09.165 Get It

P1‐262: Genetic Variants Influencing Human Longevity from Late‐Onset Alzheimer's Disease (LOAD) Genome‐Wide Association Studies (GWAS)
Shi, Hui , Medway, Christopher, Brown, Kristelle, Kalsheker, Noor , Proitsi, Petroula , Powell, John , Carrasquillo, Minerva M., Younkin, Steven G., Goate, Alison , Lovestone, Simon

Mayo Clinic

Alzheimer's & Dementia | January 12, 2012 | Volume: 7 | Issue: 4S_Part_6 | Pages: No page available

10.1016/j.jalz.2011.05.542 Get It

Exposure to inhibitors of the renin‐angiotensin system is a major independent risk factor for acute renal failure induced by sucrose containing intravenous immunoglobulins. A case‐control study
Onuigbo, Macaulay

Mayo Clinic

Pharmacoepidemiology and Drug Safety | January 12, 2012 | Volume: 21 | Issue: 3 | Pages: 320-322

10.1002/pds.2273 | PMID 22238243 Get It

Evaluation of the Yeast Traffic Light PNA FISH Probes for Identification of Candida Species from Positive Blood Cultures
Hall, Leslie, Febre, Kara M. Le, Deml, Sharon M., Wohlfiel, Sherri L., Wengenack, Nancy L.

Mayo Clinic

Journal of Clinical Microbiology | January 12, 2012 | Volume: 50 | Issue: 4 | Pages: 1446-1448

10.1128/jcm.06148-11 | PMID 22238445 Get It

ABSTRACT The Yeast Traffic Light PNA FISH kit (YTL) correctly identified Candida spp. in 207/216 (96%) positive blood cultures. Discordant results were seen with known cross-reacting species and cultures containing Candida lambica and Rhodotorula mucilaginosa . The YTL provides rapid, reliable identification of the five common Candida species found in blood cultures.
Interferon-gamma release assay T-SPOT®.TB and HIV-related tuberculosis [Correspondence]
Sattah, Martin V., Aye, San San, Azen, Colleen, Kort, Jens J., Escalante, Patricio , Jones, Brenda E.

Mayo Clinic

The International Journal of Tuberculosis and Lung Disease | January 11, 2012 | Volume: 16 | Issue: 2 | Pages: 281-282

10.5588/ijtld.11.0441 | PMID 22236936 Get It

Activity of topotecan 21-day infusion in patients with previously treated large cell lymphoma: long-term follow-up of an Eastern Cooperative Oncology Group study (E5493)
Wiernik, Peter H. , Li, Hailun , Weller, Edie, Höchster, Howard S. , Horning, Sandra J., Nazeer, Tipu, Gordon, Leo I. , Minniti, Carl J., Shapiro, Gary R., Cassileth, Peter A., Habermann, Thomas M. , Gordon, Leo I

Mayo Clinic

Leukemia & Lymphoma | January 11, 2012 | Volume: 53 | Issue: 6 | Pages: 1137-1142

10.3109/10428194.2011.643406 | PMID 22111940 Get It

Dynamic phosphometabolomic profiling of human tissues and transgenic models by18O-assisted31P NMR and mass spectrometry
Nemutlu, Emirhan , Gupta, Anu, Juranić, Nenad, Dzeja, Petras P. , Zhang, Song , Macura, Slobodan , Terzic, André , Jahangir, Arshad

Mayo Clinic

Physiological Genomics | January 11, 2012 | Volume: 44 | Issue: 7 | Pages: 386-402

10.1152/physiolgenomics.00152.2011 | PMID 22234996 Get It

Next-generation screening of disease-related metabolomic phenotypes requires monitoring of both metabolite levels and turnover rates. Stable isotope18O-assisted31P nuclear magnetic resonance (NMR) and mass spectrometry uniquely allows simultaneous measurement of phosphometabolite levels and turnover rates in tissue and blood samples. The18O labeling procedure is based on the incorporation of one18O into Pifrom [18O]H2O with each act of ATP hydrolysis and the distribution of18O-labeled phosphoryls among phosphate-carrying molecules. This enables simultaneous recording of ATP synthesis and utilization, phosphotransfer fluxes through adenylate kinase, creatine kinase, and glycolytic pathways, as well as mitochondrial substrate shuttle, urea and Krebs cycle activity, glycogen turnover, and intracellular energetic communication. Application of expanded18O-labeling procedures has revealed significant differences in the dynamics of G-6-P[18O] (glycolysis), G-3-P[18O] (substrate shuttle), and G-1-P[18O] (glycogenolysis) between human and rat atrial myocardium. In human atria, the turnover of G-3-P[18O], which defects are associated with the sudden death syndrome, was significantly higher indicating a greater importance of substrate shuttling to mitochondria. Phosphometabolomic profiling of transgenic hearts deficient in adenylate kinase (AK1−/−), which altered levels and mutations are associated to human diseases, revealed a stress-induced shift in metabolomic profile with increased CrP[18O] and decreased G-1-P[18O] metabolic dynamics. The metabolomic profile of creatine kinase M-CK/ScCKmit−/−-deficient hearts is characterized by a higher G-6-[18O]P turnover rate, G-6-P levels, glycolytic capacity, γ/β-phosphoryl of GTP[18O] turnover, as well as β-[18O]ATP and β-[18O]ADP turnover, indicating altered glycolytic, guanine nucleotide, and adenylate kinase metabolic flux. Thus,18O-assisted gas chromatography-mass spectrometry and31P NMR provide a suitable platform for dynamic phosphometabolomic profiling of the cellular energetic system enabling prediction and diagnosis of metabolic diseases states.